1. Home/
  2. Compounds/
  3. navitoclax:sorafenib (1:1 mol/mol)

navitoclax:sorafenib (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:sorafenib (1:1 mol/mol)
PharmacoGx navitoclax:sorafenib (1:1 mol/mol)

Cell lines tested with navitoclax:sorafenib (1:1 mol/mol)

835 cell lines have been tested with this compound, using data from 1 dataset(s).
A549 lung CTRPv23
DU-145 prostate CTRPv22
AsPC-1 pancreas CTRPv22
NCI-H1869 lung CTRPv22
CCF-STTG1 central nervous system CTRPv22
OAW-28 ovary CTRPv22
HeLa cervix CTRPv22
LOXIMVI haematopoietic and lymphoid tissue CTRPv22
NCI-H520 lung CTRPv22
MKN74 stomach CTRPv22
Download CSV

Tissues tested with navitoclax:sorafenib (1:1 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
haematopoietic and lymphoid tissueCTRPv2154
lungCTRPv2145
N/ACTRPv248
central nervous systemCTRPv247
skinCTRPv244
large intestineCTRPv244
pancreasCTRPv241
ovaryCTRPv240
breastCTRPv236
upper aerodigestive tractCTRPv232
Download CSV
Download Data as CSV

Top molecular features associated with response to navitoclax:sorafenib (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KIAA0408 CTRPv2 AAC 0.31 9e-14
mRNA FXYD6 CTRPv2 AAC 0.27 1e-13
mRNA YPEL1 CTRPv2 AAC 0.27 1e-13
mRNA TMSB15A CTRPv2 AAC 0.28 1e-13
mRNA ZNF516 CTRPv2 AAC 0.26 2e-13
mRNA DCANP1 CTRPv2 AAC 0.25 2e-13
mRNA WDR7 CTRPv2 AAC 0.28 4e-13
mRNA SOGA3 CTRPv2 AAC 0.3 1e-12
mRNA RP3-403A15.5 CTRPv2 AAC 0.3 1e-12
mRNA ELAVL3 CTRPv2 AAC 0.31 1e-12
Download CSV